英文别名(2S,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid; (αS,γS)-γ-[[(1,1-Dimethylethoxy)carbonyl]amino]-α-methyl-[1,1-biphenyl]-4-pentanoic Acid; Sacubitril Impurity E; LCZ 696 Impurity E; LCZ706; Sacubitril Impurity 2; (2S,4S)-5-(4-Biphenylyl)-2-methyl-4-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)pentanoic acid; LCZ696 impurity 5; [1,1'-Biphenyl]-4-pentanoic acid, gamma-[[(1,1-dimethylethoxy)carbonyl]amino]-alpha-methyl-, (alphaS,gammaS)-; (2S,4S)-2-methyl-4-[(2-methylpropan-2-yl)oxycarbonylamino]-5-(4-phenylphenyl)pentanoic acid; Sacubitril Impurity 7; (2S,4S)-5-{[1,1'-biphenyl]-4-yl}-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid; LCZ-696 Impurity 17(S,S); (2S,4S)-5-{[1,1'-biphenyl]-4-yl}-4-{[(tert-butoxy)carbonyl]amino}-2-methylpentanoic acid; (2S,4S)-5-biphenyl-4-yl-4-tert-butoxycarbonylamino-2-methylpentanoic acid; (2S,4S)-4-(tert-butoxycarbonylamino)-2-methyl-5-(4-phenylphenyl)pentanoic acid; (alphaS,gammaS)-gamma-[[(1,1-Dimethylethoxy)carbonyl]amino]-alpha-methyl[1,1'-biphenyl]-4-pentanoic acid; Valsartan Impurity 45 
